A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Remco de Brouwer, Wouter P Te Rijdt, Edgar T Hoorntje, Ahmad Amin, Folkert W Asselbergs, Moniek G P J Cox, Jeroen F van der Heijden, Hans Hillege, Jacco C Karper, Belend Mahmoud, Peter van der Meer, Anton Oomen, Anneline S J M Te Riele, Herman H W Silljé, Hanno L Tan, Jan Peter van Tintelen, Dirk J van Veldhuisen, Berend Daan Westenbrink, Ans C P Wiesfeld, Tineke P WillemsPaul A van der Zwaag, Arthur A M Wilde, Rudolf A de Boer*, Maarten P van den Berg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)
28 Downloads (Pure)
Original languageEnglish
Pages (from-to)4284-4287
Number of pages4
JournalEuropean Heart Journal
Volume44
Issue number40
Early online date20-May-2023
DOIs
Publication statusPublished - 21-Oct-2023

Keywords

  • Cardiomyopathy
  • Eplerenone
  • Fibrosis
  • Heart failure
  • Phospholamban
  • Randomized clinical trial

Cite this